Nextleaf Solutions Ltd. (OILS) (
CSE.OILS,
OTC: OILFF,
Forum) has announced that its wholly-owned subsidiary, Nextleaf Labs Ltd., has received an amendment to its existing Standard Cannabis Processing Licence from Health Canada that authorizes the sale of cannabis extracts, edibles, and topical products, directly to provincially-authorized distributors and retailers across Canada.
Nextleaf’s CEO, Paul Pedersen commented:
"The receipt of this licence amendment marks a significant milestone for Nextleaf, our commercial partners, and our investors. The sales licence helps Nextleaf service our partners more efficiently. Speed-to-market and the ability to test products effectively are often just as important to our partners as the price per molecule. This sales amendment, alongside our recently announced research licence amendment, and our unrivaled technology positions Nextleaf as a top tier extraction partner. Lastly, the amendment allows us to create and manufacture our own brands and add to our bottom-line revenue as the industry waits for market equilibrium in the extracts segment."
Full news release
here.
New to investing in Cannabis? Check out Stockhouse tips on How to Invest in Cannabis Stocks and some of our Top Cannabis Stocks.
For more of the latest info on Cannabis, check out the Cannabis Trending News hub on Stockhouse.
FULL DISCLOSURE: Nextleaf Solutions Ltd. is a client of Stockhouse Publishing.